General Info

Dr. Weidhaas comes to UCLA from Yale Cancer Center where she has specialized in women's health, as head of the Breast and Gynecological services during her tenure there. She has successfully sustained NIH grant funding in microRNAs, and her laboratory works to best define the applications of microRNAs in personalized medicine. Dr. Weidhaas is a leader in translational research and holds several patents, is a co-founder of MiraDX, a molecular diagnostics company, and a founder of MiraKind, a non…